Add to ORKGAbsence of an adipogenic effect of rosiglitazone on mature 3T3-L1 adipocytes: increase of lipid catabolism and reduction of adipokine expressio
Obesity is associated with insulin resistance and type 2 diabetes, implying a role for adipose tissu...
<p>Fully differentiated 3T3-L1 adipocytes were cultured with or without Rosiglitazone (10 uM) for 48...
It is well-documented that CL316,243 (a β3 agonist) or rosiglitazone (a PPARγ agonist) can induce wh...
Aims/hypothesis: The thiazolidinedione (TZD) rosiglitazone is a peroxisome proliferator-activated re...
AIMS/HYPOTHESIS: The thiazolidinedione (TZD) rosiglitazone is a peroxisome proliferator-activated re...
Rosiglitazone is a current Type 2 diabetes drug. Two theories about rosiglitazone\u27s therapeutic m...
Aims: To accommodate surplus energy, adipose tissue expands by increasing both adipose cell size (hy...
of rosiglitazone on plasma adiponectin levels and arterial stiffness in subjects with prediabetes or...
<p>Serum A-SAA ( <i>n</i> = 8) (top) and adipose secretion of A-SAA ex vivo ( <i>n</i> = 7) (bottom)...
To better define the mechanism of action of the thiazolidinediones, we incubated freshly isolated hu...
1476-5497 (Electronic) Journal ArticleOBJECTIVE: The aim of this study is to determine the effect of...
Obesity is a major risk for diabetes. Brown adipose tissue (BAT) mediates production of heat while w...
AIMS/HYPOTHESIS: We investigated the effects of rosiglitazone on NEFA and triglyceride metabolism in...
We would like to thank Dr Cohen for his com-ments. We appreciate that rosiglitazone pro-motes adipoc...
OBJECTIVE - The purpose of this study was to examine the effects of PPAR-γ agonist rosiglitazone, re...
Obesity is associated with insulin resistance and type 2 diabetes, implying a role for adipose tissu...
<p>Fully differentiated 3T3-L1 adipocytes were cultured with or without Rosiglitazone (10 uM) for 48...
It is well-documented that CL316,243 (a β3 agonist) or rosiglitazone (a PPARγ agonist) can induce wh...
Aims/hypothesis: The thiazolidinedione (TZD) rosiglitazone is a peroxisome proliferator-activated re...
AIMS/HYPOTHESIS: The thiazolidinedione (TZD) rosiglitazone is a peroxisome proliferator-activated re...
Rosiglitazone is a current Type 2 diabetes drug. Two theories about rosiglitazone\u27s therapeutic m...
Aims: To accommodate surplus energy, adipose tissue expands by increasing both adipose cell size (hy...
of rosiglitazone on plasma adiponectin levels and arterial stiffness in subjects with prediabetes or...
<p>Serum A-SAA ( <i>n</i> = 8) (top) and adipose secretion of A-SAA ex vivo ( <i>n</i> = 7) (bottom)...
To better define the mechanism of action of the thiazolidinediones, we incubated freshly isolated hu...
1476-5497 (Electronic) Journal ArticleOBJECTIVE: The aim of this study is to determine the effect of...
Obesity is a major risk for diabetes. Brown adipose tissue (BAT) mediates production of heat while w...
AIMS/HYPOTHESIS: We investigated the effects of rosiglitazone on NEFA and triglyceride metabolism in...
We would like to thank Dr Cohen for his com-ments. We appreciate that rosiglitazone pro-motes adipoc...
OBJECTIVE - The purpose of this study was to examine the effects of PPAR-γ agonist rosiglitazone, re...
Obesity is associated with insulin resistance and type 2 diabetes, implying a role for adipose tissu...
<p>Fully differentiated 3T3-L1 adipocytes were cultured with or without Rosiglitazone (10 uM) for 48...
It is well-documented that CL316,243 (a β3 agonist) or rosiglitazone (a PPARγ agonist) can induce wh...